Targeted Cancer Therapies | sciencenewsnet.in

Breaking News

New Imaging Technique Reveals Detailed Map of Brain’s Blood Flow in 3D

RUSH Earns Innovation Award for Caregiver Support

Hackensack Meridian Pascack Valley Medical Center Earns An ‘A’ Hospital Safety Grade from The Leapfrog Group

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Hackensack Meridian Mountainside Medical Center Nurse Wins Research Award at ACC Quality Summit

Breakthrough Idea for CCU Technology Commercialization from ‘Carbon Cycle of the Earth’

Launch of nationwide map viewer and database aids wildfire planning and understanding of treatment effects

Scientists Gain New Insights into How Mass Is Distributed in Hadrons

MSU expert: What the history of lame-duck presidents can tell us about President Biden’s final actions

Helping Soldiers Serve on a Full Stomach

15 Nov, 2024

Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

September 30, 2024 sarah JonasResearch Results

The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML).

Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic Cancer

November 21, 2022 sarah JonasResearch Results

Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.

MD Anderson Research Highlights for May 4, 2022

May 4, 2022 sarah JonasResearch Tip Sheet

Featured studies include clinical advances with a new combination therapy targeting angiogenesis in platinum-resistant ovarian cancer and a promising immunotherapy combination for kidney cancer, plus laboratory studies that focus on targeting ferroptosis in specific lung cancers, developing chimeric antigen receptor (CAR) T cell therapies for blastic plasmacytoid dendritic cell neoplasms, and characterizing racial and ethnic disparities in breast cancer early detection.